William J. Link Ph.D., Director at Tarsus Pharmaceuticals, Inc. (TARS), sold 41,126 shares at $80.80 ($3.3M) on 2025-12-15, disclosed to the SEC on 2025-12-17.
Scheduled sale ($3.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.71 | 5,680 | $458K | 13.7% |
| 2 | $80.71 | 5,680 | $458K | 13.7% |
| 3 | $80.80 | 5,046 | $408K | 12.2% |
| 4 | $80.80 | 5,046 | $408K | 12.2% |
| 5 | $81.50 | 4,766 | $388K | 11.6% |
| 6 | $81.75 | 6,306 |
| $516K |
| 15.4% |
| 7 | $81.75 | 6,306 | $516K | 15.4% |
| 8 | $82.39 | 1,148 | $95K | 2.8% |
| 9 | $82.39 | 1,148 | $95K | 2.8% |
| Total | $81.24 avg | 41,126 | $3.3M | 100% |
| Filing → |
| TARS | SELL | 2026-03-18 | $860K | — | Filing → |
| TARS | SELL | 2025-09-10 | $1.5M | — | Filing → |
| TARS | SELL | 2024-08-14 | $1.8M | — | Filing → |